KLSE:TOPVISN

Stock Analysis Report

NOT FOR DISTRIBUTION

Topvision Eye Specialist Berhad

Market Cap

RM191.7m

Last Updated

2021/07/19 11:16 UTC

Data Sources

Company Financials

Executive Summary

Topvision Eye Specialist Berhad, an investment holding company, provides ophthalmology and related medical consultancy services in Malaysia. More Details


Snowflake Analysis

Acceptable track record with mediocre balance sheet.


Similar Companies

Share Price & News

How has Topvision Eye Specialist Berhad's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: Insufficient data to determine TOPVISN's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine TOPVISN's volatility change over the past year.


Market Performance


7 Day Return

0%

TOPVISN

-2.4%

MY Healthcare

-1.9%

MY Market


1 Year Return

n/a

TOPVISN

7.0%

MY Healthcare

-1.5%

MY Market

Return vs Industry: Insufficient data to determine how TOPVISN performed against the MY Healthcare industry.

Return vs Market: Insufficient data to determine how TOPVISN performed against the MY Market.


Shareholder returns

TOPVISNIndustryMarket
7 Day0%-2.4%-1.9%
30 Day0%1.0%-1.3%
90 Dayn/a4.4%-6.6%
1 Yearn/a7.8%7.0%2.1%-1.5%
3 Yearn/a-0.9%-3.2%-3.7%-12.8%
5 Yearn/a-9.8%-13.1%8.6%-9.6%

Long-Term Price Volatility Vs. Market

How volatile is Topvision Eye Specialist Berhad's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Topvision Eye Specialist Berhad undervalued compared to its fair value and its price relative to the market?

129.83x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: TOPVISN (MYR0.75) is trading above our estimate of fair value (MYR0.05)

Significantly Below Fair Value: TOPVISN is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: TOPVISN is poor value based on its PE Ratio (129.8x) compared to the MY Healthcare industry average (55.8x).

PE vs Market: TOPVISN is poor value based on its PE Ratio (129.8x) compared to the MY market (17.3x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate TOPVISN's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: TOPVISN is overvalued based on its PB Ratio (10.1x) compared to the MY Healthcare industry average (3.3x).


Future Growth

How is Topvision Eye Specialist Berhad forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

20.3%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Topvision Eye Specialist Berhad has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Topvision Eye Specialist Berhad performed over the past 5 years?

4.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: TOPVISN has high quality earnings.

Growing Profit Margin: TOPVISN's current net profit margins (6.6%) are lower than last year (6.8%).


Past Earnings Growth Analysis

Earnings Trend: TOPVISN's earnings have grown by 4.6% per year over the past 5 years.

Accelerating Growth: TOPVISN's earnings growth over the past year (1.4%) is below its 5-year average (4.6% per year).

Earnings vs Industry: TOPVISN earnings growth over the past year (1.4%) exceeded the Healthcare industry -7.8%.


Return on Equity

High ROE: TOPVISN's Return on Equity (7.8%) is considered low.


Financial Health

How is Topvision Eye Specialist Berhad's financial position?


Financial Position Analysis

Short Term Liabilities: TOPVISN's short term assets (MYR10.4M) exceed its short term liabilities (MYR3.3M).

Long Term Liabilities: TOPVISN's short term assets (MYR10.4M) do not cover its long term liabilities (MYR12.9M).


Debt to Equity History and Analysis

Debt Level: TOPVISN's debt to equity ratio (45.6%) is considered high.

Reducing Debt: Insufficient data to determine if TOPVISN's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: TOPVISN's debt is well covered by operating cash flow (46.4%).

Interest Coverage: TOPVISN's interest payments on its debt are well covered by EBIT (7.4x coverage).


Balance Sheet


Dividend

What is Topvision Eye Specialist Berhad current dividend yield, its reliability and sustainability?

0.67%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: TOPVISN's dividend (0.67%) isn’t notable compared to the bottom 25% of dividend payers in the MY market (1.52%).

High Dividend: TOPVISN's dividend (0.67%) is low compared to the top 25% of dividend payers in the MY market (4.16%).


Stability and Growth of Payments

Stable Dividend: TOPVISN is not paying a notable dividend for the MY market, therefore no need to check if payments are stable.

Growing Dividend: TOPVISN is not paying a notable dividend for the MY market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: TOPVISN is not paying a notable dividend for the MY market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of TOPVISN's dividend in 3 years as they are not forecast to pay a notable one for the MY market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.3yrs

Average board tenure


CEO

Kenny Liew (65 yo)

no data

Tenure

Mr. Hock Nean Liew, also known as Kenny, is Founder, Chief Executive Officer at TOPVISION Eye Specialist Berhad and it’s Executive Director since March 27, 2018. He served as Vice President of Marketing an...


Board Members

Experienced Board: TOPVISN's board of directors are considered experienced (3.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Topvision Eye Specialist Berhad's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Topvision Eye Specialist Berhad
  • Ticker: TOPVISN
  • Exchange: KLSE
  • Founded: 2010
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: RM191.697m
  • Shares outstanding: 255.60m
  • Website: https://www.tvesc.com

Number of Employees


Location

  • Topvision Eye Specialist Berhad
  • Setia Avenue: Unit 11-2 & 11-3
  • No.2,Block 2, Jalan Setia Prima(S) U13/S
  • Shah Alam
  • Selangor
  • 40170
  • Malaysia

Listings


Biography

Topvision Eye Specialist Berhad, an investment holding company, provides ophthalmology and related medical consultancy services in Malaysia. It offers various eye care services comprising cataract, pterygi...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/07/19 11:16
End of Day Share Price2021/04/21 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.